These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 14080014)

  • 1. [EXPERIENCE IN VACCINATION WITH ATTENUATED MEASLES VIRUS. 3. IMMUNOLOGIC AND EPIDEMIOLOGIC STUDY AFTER A YEAR OF OBSERVATION].
    HEVIA P; RODRIGUEZ M; UNDURRAGA O; ROSSELOT J; MENEGHELLO J
    Pediatria (Santiago); 1963; 6():151-6. PubMed ID: 14080014
    [No Abstract]   [Full Text] [Related]  

  • 2. [EXPERIENCE IN VACCINATION WITH ATTENUATED MEASLES VIRUS. CLINICAL, IMMUNOLOGIC AND EPIDEMIOLOGIC STUDY IN 50 INFANTS].
    MENEGHELLO J; UNDURRAGA O; ROSSELOT J; RODRIGUEZ M; HEVIA P
    Rev Chil Pediatr; 1963 Aug; 34():650-5. PubMed ID: 14089201
    [No Abstract]   [Full Text] [Related]  

  • 3. [FURTHER OBSERVATIONS ON THE PROTECTIVE EFFECTS AND SEROLOGICAL RESPONSE IN CHILDREN IMMUNIZED WITH KILLED MEASLES VIRUS VACCINE].
    BRANCATO P; GULLO A; ALBANESE M
    Riv Ist Sieroter Ital; 1964; 39():287-92. PubMed ID: 14177289
    [No Abstract]   [Full Text] [Related]  

  • 4. INACTIVATED MEASLES VIRUS VACCINE SUBSEQUENTLY CHALLENGED WITH LIVE ATTENUATED MEASLES VIRUS VACCINE.
    KIMURA M; ISHIGURO Y
    Jpn J Med Sci Biol; 1965 Feb; 18():65-71. PubMed ID: 14300296
    [No Abstract]   [Full Text] [Related]  

  • 5. GLOBULIN-MODIFIED VACCINATION WITH LIVE ATTENUATED MEASLES VIRUS, SUGIYAMA, ADAPTED TO BOVINE RENAL CELLS.
    MINAMITANI M; NAKAMURA K; SHINOZAKI T; TAKAHASHI T; FUJII R; SABURI Y; MATUMOTO M
    Jpn J Exp Med; 1964 Apr; 34():85-8. PubMed ID: 14171677
    [No Abstract]   [Full Text] [Related]  

  • 6. CLINICAL AND SEROLOGICAL OBSERVATIONS ON THE CHILDREN GIVEN ATTENUATED MEASLES VACCINE.
    ARAI M; NAKAMURA M; AKAMATSU T; KIMURA M; KITAYAMA T; KOIDE G
    Acta Paediatr Jpn; 1963 Dec; 14():9-16. PubMed ID: 14200614
    [No Abstract]   [Full Text] [Related]  

  • 7. MEASLES IMMUNIZATION WITH KILLED VIRUS VACCINE. SERUM ANTIBODY TITERS AND EXPERIENCE WITH EXPOSURE TO MEASLES EPIDEMIC.
    RAUH LW; SCHMIDT R
    Am J Dis Child; 1965 Mar; 109():232-7. PubMed ID: 14246070
    [No Abstract]   [Full Text] [Related]  

  • 8. [Measles vaccination].
    Enders G
    Zentralbl Bakteriol Orig A; 1972 May; 220(1):273-83. PubMed ID: 4145578
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunologic evaluation of measles vaccine in preschool and school children].
    Soto C; Cordero J; Vergara MI
    Rev Chil Pediatr; 1981; 52(6):491-5. PubMed ID: 7347862
    [No Abstract]   [Full Text] [Related]  

  • 10. [HISTORY AND SUSCEPTIBILITY TO MEASLES].
    QUAPPE R; MORENO M; MACHUCA M
    Rev Chil Pediatr; 1965 Feb; 31():128-33. PubMed ID: 14327892
    [No Abstract]   [Full Text] [Related]  

  • 11. COMBINED USE OF HUMAN GAMMA-GLOBULIN AND LIVE MEASLES-VIRUS VACCINE WITH REFERENCE TO SINGLE INOCULATION OF LIVE MEASLES-VIRUS VACCINE IN EARLY INFANCY.
    FUJII R; MINAMITANI M; NAKAMURA K
    Jpn J Med Sci Biol; 1965 Feb; 18():56-64. PubMed ID: 14300295
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on further attenuated liver measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine.
    Okuno Y; Ueda S; Kurimura T; Suzuki N; Yamanishi K
    Biken J; 1971 Sep; 14(3):253-8. PubMed ID: 5167868
    [No Abstract]   [Full Text] [Related]  

  • 13. VACCINATION BY RESPIRATORY ROUTE WITH LIVE ATTENUATED MEASLES VIRUS, SUGIYAMA, ADAPTED TO BOVINE REA RESPIRATORY ROUTE WITH LIVE ATTENUATED MEASLES VIRUS, SUGIYAMA, ADAPTED TO BOVINE RENAL CELLS.
    MINAMITANI M; NAKAMURA K; NAGAHAMA H; FUJII R; SABURI Y; MATUMOTO M
    Jpn J Exp Med; 1964 Apr; 34():81-4. PubMed ID: 14169587
    [No Abstract]   [Full Text] [Related]  

  • 14. A CONTROLLED TRIAL OF LIVER-VIRUS VACCINE AGAINST MEASLES IN CHILE.
    RISTORI C; BOCCARDO H; MIRANDA M; BORGONO M
    Bull World Health Organ; 1964; 30(6):763-8. PubMed ID: 14215183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CIRCULATING INTERFERON AFTER MEASLES VACCINATION.
    PETRALLI JK; MERIGAN TC; WILBUR JR
    N Engl J Med; 1965 Jul; 273():198-201. PubMed ID: 14306336
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on further attenuated liver measles vaccine. VI. Clinical and serological follow-up one year after vaccination.
    Ueda S; Takahashi M; Kurimura T; Suzuki N; Yamanishi K
    Biken J; 1971 Sep; 14(3):247-51. PubMed ID: 4258008
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical study on vaccination by measles vaccine].
    Sakano Y
    Nihon Shonika Gakkai Zasshi; 1966 Jul; 70(7):650-61. PubMed ID: 6005807
    [No Abstract]   [Full Text] [Related]  

  • 18. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children].
    Unalan H; Ustaçelebi S
    Mikrobiyol Bul; 1985 Oct; 19(4):218-28. PubMed ID: 3831724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RESPONSE OF VOLTA CHILDREN TO LIVE ATTENUATED MEASLES VIRUS VACCINE.
    MEYER HM; HOSTETLER DD; BERNHEIM BC; ROGERS NG; LAMBIN P; CHASSARY A; SMADEL JE
    Bull World Health Organ; 1964; 30(6):769-81. PubMed ID: 14215184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Measles vaccination. Israeli studies with live attenuated measles virus vaccine and gamma globulin].
    LEVIN S; MOSES S; SHIMANSKY L; KRUGMAN S
    Harefuah; 1962 Sep; 63():161-6. PubMed ID: 14464579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.